Kajiura, Shinya <br/><br/>
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.  [electronic resource] 

 -  American journal of clinical oncology  Feb 2016 
 - 13-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0000000000000018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Esophageal Neoplasms--drug therapy<br/>Esophageal Squamous Cell Carcinoma<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leukopenia--chemically induced<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymph Nodes--pathology<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neutropenia--chemically induced<br/>Organoplatinum Compounds--administration & dosage<br/>Taxoids--administration & dosage<br/>Treatment Failure<br/>Vomiting--chemically induced